Effects of ketamine infusion rate and cumulative dosing on incidence of delirium in medical intensive care unit patients

Clicks: 20
ID: 331509
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #114 of 247 articles by views in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 247 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
PURPOSE: Ketamine is increasingly used for analgosedation in mechanically ventilated intensive care unit (ICU) patients, but its association with delirium remains unclear. This study evaluated the relationship between maximum hourly ketamine rate and cumulative dose during hospitalization, with the incidence of delirium. METHODS: This multicenter retrospective cohort study included mechanically ventilated adult medical ICU patients who received ketamine infusions for sedation (January 2013-June 2025) at two tertiary centers. Data collected included demographics, sedation requirements, and daily Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). The primary outcome was delirium at any point during ICU stay. Primary and secondary exposure variables included maximum hourly ketamine rate and cumulative ketamine dose. A modified Poisson regression was used to evaluate associations between the exposure variables and incidence of delirium, adjusting for confounders. RESULTS: Of 837 screened patients, 114 met inclusion criteria and 42 (36.8%) developed delirium. Baseline characteristics were similar. Patients with delirium had longer duration of mechanical ventilation, (210.7 vs 140.9 hours, P <0.01), ICU length of stay (364.7 vs 268.6 hours, P =0.04), and higher morphine milligram equivalents (5,126.8 vs 2911.8, P = 0.04). No association was observed between delirium with maximum hourly ketamine rate (RR 1.15, P = 0.21) or cumulative dose (RR 1.0, p=0.97). Restricted cubic spline analysis showed a trend towards increased delirium risk with increasing maximum hourly ketamine rates (P = 0.06). CONCLUSION: Maximum hourly ketamine infusion rate and cumulative dose in mechanical ventilated patients in the medical ICU were not associated with ICU delirium.
Reference Key
openalex_W7220443869 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Jennifer Miller, Justin Johnson, Carryl Laserna, Alexis Grady, Sarah Dubin, Ceno Fraire, Brooke A. Smith, Kelli Henry
Are you one of these authors? Claim your profile
Journal American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Year 2026
DOI
10.1093/ajhp/zxag326
URL
https://doi.org/10.1093/ajhp/zxag326
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.